Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intra-arterial Lutetium-177-dotatate for Treatment of Patients With Neuro-endocrine Tumor Liver Metastases

NCT03590119 is registered in ClinicalTrials.gov with Marnix Lam as lead sponsor.

NCT NCT03590119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03590119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intra-arterial Lutetium-177-dotatate for Treatment of Patients With Neuro-endocrine Tumor Liver Metastases
Lead sponsor
Marnix Lam
Phase
Phase 2/3
Overall status
Completed
Start date
August 1, 2018
Completion date
September 1, 2022
Enrollment
26 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

liver metastases, neuroendocrine tumors